Team Deloitte recognized for their dedication to the Jimmy Fund, supporting adult and pediatric patient care and cancer research at Dana-Farber Cancer Institute
BOSTON — Team Deloitte* was recognized with a Lifetime Achievement Award for their outstanding efforts for the Jimmy Fund Walk presented by Hyundai. Team Deloitte was among a select group of awardees recognized for their fundraising and commitment to the 36th Jimmy Fund Walk, held last October. 2024 was another exceptional year, with nearly $9.4 million raised for adult and pediatric cancer care and research at Dana-Farber.
More than 8,400 walkers and 1,000 volunteers came together for the event. Among them was Team Deloitte, which has participated in the Walk since 2001 and surpassed $1M raised last year. Most recently, the team has been captained by Reading, Mass., resident Mary Beth Neville, who has continued Team Deloitte’s long tradition of rallying colleagues to participate. Mary Beth is also a proud member of the Jimmy Fund Walk Advisory Board.
“Every year, we witness the profound commitment, passion, and dedication from individuals who unite against cancer to support this event. Their efforts raise funds that advance critical research and exceptional patient care at Dana-Farber,” said Caitlin Fink, vice president of the Jimmy Fund. “Team Deloitte has demonstrated a strong commitment to defying cancer and exemplifies the spirit of this event. We are proud to honor Team Deloitte with a Lifetime Achievement Award to recognize all they do for Dana-Farber and the Jimmy Fund.”
In 2024, participants had the option to choose from four distances along the Boston Marathon® course: a 5K walk from Dana-Farber, a 10K walk from Newton, a Half Marathon walk from Wellesley, or the full Boston Marathon route starting in Hopkinton. Walkers could also participate virtually in their own communities.
Over its 36-year history, the Jimmy Fund Walk has raised more than $185 million for Dana-Farber. Funds raised from the Jimmy Fund Walk support all forms of adult and pediatric patient care and cancer research at the Institute. Hyundai has proudly served as the presenting sponsor for more than 20 years.
The 2025 Jimmy Fund Walk will be held on Sunday, October 5. To register for the Walk (#JimmyFundWalk) or to support a walker, visit www.JimmyFundWalk.org or call (866) 531-9255. Registrants can enter the promo code NEWS for $5 off the registration fee. All registered walkers will receive a bib, medal, and a Jimmy Fund Walk T-shirt.
About the Jimmy Fund
The Jimmy Fund is comprised of community-based fundraising events and other programs that, solely and directly, benefit Dana-Farber Cancer Institute’s lifesaving mission to provide compassionate patient care and groundbreaking cancer research for children and adults. The Jimmy Fund is an official charity of the Boston Red Sox, the Massachusetts Chiefs of Police Association, the Pan-Mass Challenge, and the Variety Children’s Charity of New England. Since 1948, the generosity of millions of people has helped the Jimmy Fund save countless lives and reduce the burden of cancer for patients and families worldwide. Follow the Jimmy Fund on Facebook, X, and Instagram: @TheJimmyFund.
About Dana-Farber Cancer Institute
Dana-Farber Cancer Institute is one of the world’s leading centers of cancer research and treatment. Dana-Farber’s mission is to reduce the burden of cancer through scientific inquiry, clinical care, education, community engagement, and advocacy. Dana-Farber is a federally designated Comprehensive Cancer Center and a teaching affiliate of Harvard Medical School.
We provide the latest treatments in cancer for adults through Dana-Farber Brigham Cancer Center and for children through Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. Dana-Farber is the only hospital nationwide with a top 5 U.S. News & World Report Best Cancer Hospital ranking in both adult and pediatric care. As a global leader in oncology, Dana-Farber is dedicated to a unique and equal balance between cancer research and care, translating the results of discovery into new treatments for patients locally and around the world, offering more than 1,100 clinical trials.
*Please see www.deloitte.com/us/about for a detailed description of their legal structure.
